Intranasal administration of oxytocin in children with Prader-Willi Syndrome. A randomized, open-label, cross-over trial of different treatment regimens of oxytocin administration. Effects on eating behaviour and social behaviour.
Phase of Trial: Phase III
Latest Information Update: 20 Jan 2017
At a glance
- Drugs Oxytocin (Primary)
- Indications Prader-Willi syndrome
- Focus Therapeutic Use
- 20 Jan 2017 New trial record